Subclinical diabetic neuropathy with normal conventional electrophysiological study

Journal of Neurology

Volumn 254, Issue 1, 2007, Pages 53-59

  Bae, Jong Seok ^a   Kim, Byoung Joon ^b  

^a Inje University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Diabetic neuropathy; Modified F ratio; Residual latency; Subclinical; Terminal latency index

Indexed keywords

ADULT; ARM; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC VALUE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; LATENT PERIOD; LEG; MALE; NERVE CONDUCTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ANALYSIS OF VARIANCE; DIABETIC NEUROPATHIES; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EXTREMITIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; REACTION TIME; REFERENCE VALUES; RETROSPECTIVE STUDIES; TIBIAL NERVE; ULNAR NERVE;

EID: 33847168476     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0261-5     Document Type: Article

References (29)

1. (1988) Report and recommendations of the San Antonio conference on diabetic neuropathy. Neurology 38:1161-1165
2. Attarian S, Azulay JP, Boucraut J, Escande N, Pouget J (2001) Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol 112:457-463
3. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46:878-884
4. Bril V (1999) NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 41 (Suppl 1):8-13
5. Bril V, Werb MR, Greene DA, Sima AA (1996) Single-fiber electromyography in diabetic peripheral polyneuropathy. Muscle Nerve 19:2-9
6. Bromberg MB (1991) Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 14:968-976
7. Brown MJ, Asbury AK (1984) Diabetic neuropathy. Ann Neurol 15:2-12
8. Chang CW, Chuang LM (1996) Correlation of HbA1c concentration and single-fiber EMG findings in diabetic neuropathy. Electromyogr Clin Neurophysiol 36:425-432
9. Cocito D, Isoardo G, Ciaramitaro P, Migliaretti G, Pipieri A, Barbero P, Cucci A, Durelli L (2001) Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody. Muscle Nerve 24:1278-1282
10. Daube J (1996) Compound muscle action potentials. In: Daube J (eds) Clinical neurophysiology. FA Davis Company, Philadelphia, pp 199-324
11. Dyck PJ (1992) New understanding and treatment of diabetic neuropathy. N Engl J Med 326:1287-1288
12. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, 3rd, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, et al. (1991) The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807
13. Dyck PJ, O'Brien PC (1989) Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 12:649-652
14. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289
15. Kaku DA, England JD, Sumner AJ (1994) Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 117(Pt 5):941-947
16. Kaplan P, Sahgal V (1978) Residual latency: new applications of an old technique. Arch Phys Med Rehabil 59:24-27
17. Kaplan PE (1976) Sensory and motor residual latency measurements in helathy patients and patients with neuropathy-part 1. J Neurol Neurosurg Psychiatry 39:338-340
18. Kimura J, Yamada T, Stevland NP (1979) Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy. J Neurol Sci 42:291-302
19. Olaleye D, Perkins BA, Bril V (2001) Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract 54:115-128
20. Pastore C, Izura V, Geijo-Barrientos E, Dominguez JR (1999) A comparison of electrophysiological tests for the early diagnosis of diabetic neuropathy. Muscle Nerve 22:1667-1673
21. Perkins BA, Olaleye D, Zinman B, Bril V (2001) Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 24:250-256
22. Radziwill AJ, Steck AJ, Renaud S, Fuhr P (2003) Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy. J Neurol 250:962-966
23. Rith-Najarian SJ, Stolusky T, Gohdes DM (1992) Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 15:1386-1389
24. Sander HW, Latov N (2003) Research criteria for defining patients with CIDP. Neurology 60:S8-S15
25. Shahani BT, Young RR, Potts F, Maccabee P (1979) Terminal latency index(TLI) and late response studies in motor neuron disease(MND), peripheral neuropathies and entrapment syndromes (abstract). Acta Neurol Scand Supp. 73:118
26. Shimada H, Kihara M, Kosaka S, Ikeda H, Kawabata K, Tsutada T, Miki T (2001) Comparison of SSR and QSART in early diabetic neuropathy-the value of length-dependent pattern in QSART. Auton Neurosci 92:72-75
27. Simovic D, Weinberg DH (1999) The median nerve terminal latency index in carpal tunnel syndrome: a clinical case selection study. Muscle Nerve 22:573-577
28. Simovic D, Weinberg DH (1997) Terminal latency index in the carpal tunnel syndrome. Muscle Nerve 20:1178-1180
29. Trojaborg W, Hays AP, van den Berg L, Younger DS, Latov N (1995) Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18:730-735